The Cigna Group (NYSE:CI) Shares Sold by Boston Partners

Boston Partners trimmed its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 62.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 643,307 shares of the health services provider's stock after selling 1,080,728 shares during the period. Boston Partners owned approximately 0.23% of The Cigna Group worth $177,829,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of CI. TCTC Holdings LLC bought a new position in The Cigna Group in the 4th quarter worth $25,000. Collier Financial bought a new stake in shares of The Cigna Group in the fourth quarter worth about $32,000. ORG Wealth Partners LLC purchased a new position in The Cigna Group in the fourth quarter worth about $34,000. Prospera Private Wealth LLC purchased a new position in The Cigna Group in the third quarter worth about $37,000. Finally, Compagnie Lombard Odier SCmA purchased a new position in The Cigna Group in the fourth quarter worth about $37,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

The Cigna Group Price Performance

Shares of CI stock traded down $4.61 during mid-day trading on Friday, hitting $316.78. 3,552,779 shares of the stock were exchanged, compared to its average volume of 1,566,129. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The firm has a fifty day moving average of $300.83 and a 200 day moving average of $315.05. The company has a market cap of $86.70 billion, a PE ratio of 25.88, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the company posted $6.79 EPS. Research analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were issued a $1.51 dividend. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 1.91%. The Cigna Group's dividend payout ratio is presently 49.35%.

Insider Buying and Selling at The Cigna Group

In other news, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares of the company's stock, valued at $4,289,920. The trade was a 42.59 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,751 shares of company stock worth $13,603,991. Insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Cantor Fitzgerald boosted their target price on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research report on Thursday. UBS Group reduced their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Stephens reduced their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Barclays reduced their price target on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a research report on Friday, January 31st. Finally, Wells Fargo & Company reduced their price target on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $373.25.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.